_uclamedtech2022-review-fda-cdrh-2021-annual-report-and-20222025-strategic-priorities-preview-1.jpg "#UCLAMedTech2022 REVIEW FDA CDRH 2021 ANNUAL REPORT AND 2022–2025 STRATEGIC PRIORITIES from fda annual report Video Screenshot Preview 1")
Gallery_uclamedtech2022-review-fda-cdrh-2021-annual-report-and-20222025-strategic-priorities-preview-3.jpg "#UCLAMedTech2022 REVIEW FDA CDRH 2021 ANNUAL REPORT AND 2022–2025 STRATEGIC PRIORITIES from fda annual report Video Screenshot Preview 3")
Gallery_uclamedtech2022-review-fda-cdrh-2021-annual-report-and-20222025-strategic-priorities-preview-hqdefault.jpg "#UCLAMedTech2022 REVIEW FDA CDRH 2021 ANNUAL REPORT AND 2022–2025 STRATEGIC PRIORITIES from fda annual report Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 23 minutes 34 seconds
👁 View: 9 times
Play Audio:👁 View: 9 times
Description:
UCLA TDG
UCLA TDG
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_navigating-fda39s-drug-information-resources.webp "U.S. Food and Drug Administration")
_components-of-new-drug-application-and-biologics-license-application-5of15-redi-may-29-30-2019.webp "U.S. Food and Drug Administration")
⏲ 36 minutes 55 seconds 👁 5.7K
_an-overview-of-fda39s-project-facilitate-oncology-expanded-access-program.webp "U.S. Food and Drug Administration")
⏲ 50 minutes 9 seconds 👁 1.2K
_fda-inspections-part-1.webp "Compliance Insight")
_types-of-anda-amendmemts-usfda-supac-guidelines-pas-cbe.webp "Pharmoctor by A NIPERIAN")
_april-12-2024-meeting-of-the-oncologic-drugs-advisory-committee-odac.webp "U.S. Food and Drug Administration")
⏲ 6 hours 49 minutes 31 seconds 👁 5.4K
_fda39s-rare-disease-day-2024dedicated-to-patients-and-providers.webp "U.S. Food and Drug Administration")
⏲ 7 hours 34 minutes 28 seconds 👁 2.4K
_fda-inspections-of-compounding-outsourcing-facilities.webp "U.S. Food and Drug Administration")
_navigating-fda39s-drug-information-resources.jpg)
_components-of-new-drug-application-and-biologics-license-application-5of15-redi-may-29-30-2019.jpg)
_an-overview-of-fda39s-project-facilitate-oncology-expanded-access-program.jpg)
_fda-inspections-part-1.jpg)
_types-of-anda-amendmemts-usfda-supac-guidelines-pas-cbe.jpg)
_april-12-2024-meeting-of-the-oncologic-drugs-advisory-committee-odac.jpg)
_fda39s-rare-disease-day-2024dedicated-to-patients-and-providers.jpg)
_fda-inspections-of-compounding-outsourcing-facilities.jpg)
![[+]](/images/menu.gif){kind=small}